학술논문
Pembrolizumab versus placebo in addition to carboplatin and paclitaxel for measurable stage 3 or 4a, stage 4b or recurrent endometrial cancer: The phase 3, NRG GY018 study (LBA 10)
Document Type
Abstract
Author
Eskander, Ramez; Sill, Michael; Beffa, Lindsey; Moore, Richard; Hope, Joanie; Musa, Fernanda; Mannel, Robert; Shahin, Mark; Cantuaria, Guilherme; Girda, Eugenia; Mathews, Cara; Kavecansky, Juraj; Leath, Charles; Gien, Lilian; Hinchcliff, Emily; Lele, Shashikant; Landrum, Lisa; Backes, Floor; O'Cearbhaill, Róisín; Liu, Rebecca; Hill, Emily; Thaker, Premal; John, Veena; Powell, Matthew; Aghajanian, Carol
Source
In Gynecologic Oncology September 2023 176 Supplement 1:S42-S43
Subject
Language
ISSN
0090-8258